U.S. Markets open in 7 hrs 32 mins

Healthcare firms say Qsymia prescriptions rose, Reuters reports

Healthcare research firm Symphony Health Solutions reported a 44% jump in prescriptions for VIVUS' (VVUS) weight loss drug Qsymia for the week ended November 12, according to Reuters. Another firm, IMS Health, pointed to a more modest 15% rise in prescriptions during the same period, according to a Cowen & Co analyst, Reuters added.